| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoclasts | 10 | 2016 | 132 | 2.110 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 8 | 2016 | 28 | 1.920 |
Why?
|
| Cell Differentiation | 7 | 2016 | 1034 | 1.160 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2016 | 134 | 1.020 |
Why?
|
| DNA Helicases | 2 | 2013 | 64 | 0.800 |
Why?
|
| Promoter Regions, Genetic | 10 | 2013 | 614 | 0.770 |
Why?
|
| Trans-Activators | 4 | 2009 | 237 | 0.730 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 271 | 0.720 |
Why?
|
| Transcription Factors | 4 | 2013 | 753 | 0.710 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2009 | 411 | 0.680 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 247 | 0.610 |
Why?
|
| Microphthalmos | 1 | 2016 | 9 | 0.560 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 562 | 0.480 |
Why?
|
| NFATC Transcription Factors | 3 | 2008 | 40 | 0.460 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 56 | 0.460 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 5 | 2016 | 49 | 0.460 |
Why?
|
| RANK Ligand | 5 | 2016 | 73 | 0.420 |
Why?
|
| Signal Transduction | 6 | 2018 | 2688 | 0.390 |
Why?
|
| Mice | 21 | 2022 | 8472 | 0.370 |
Why?
|
| Osteopetrosis | 1 | 2009 | 8 | 0.350 |
Why?
|
| Mutation | 2 | 2016 | 1213 | 0.330 |
Why?
|
| Cathepsin K | 5 | 2013 | 16 | 0.330 |
Why?
|
| Osteogenesis | 1 | 2009 | 152 | 0.310 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 4 | 2013 | 22 | 0.310 |
Why?
|
| Acid Phosphatase | 4 | 2013 | 36 | 0.300 |
Why?
|
| Animals | 24 | 2022 | 20877 | 0.290 |
Why?
|
| NF-kappa B | 4 | 2019 | 432 | 0.270 |
Why?
|
| Isoenzymes | 4 | 2013 | 308 | 0.270 |
Why?
|
| Cathepsins | 4 | 2009 | 37 | 0.270 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2018 | 20 | 0.260 |
Why?
|
| Genomics | 1 | 2006 | 167 | 0.250 |
Why?
|
| Stromal Cells | 3 | 2016 | 113 | 0.250 |
Why?
|
| Fibroblasts | 5 | 2022 | 902 | 0.240 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 1293 | 0.240 |
Why?
|
| Phosphorylation | 3 | 2016 | 1199 | 0.220 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 46 | 0.210 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2021 | 19 | 0.210 |
Why?
|
| Neuroprotection | 1 | 2021 | 28 | 0.200 |
Why?
|
| Macrophages | 3 | 2010 | 647 | 0.200 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 102 | 0.180 |
Why?
|
| Nanofibers | 1 | 2019 | 21 | 0.170 |
Why?
|
| Antigens, CD34 | 1 | 2019 | 75 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 332 | 0.170 |
Why?
|
| Cells, Cultured | 5 | 2018 | 2673 | 0.160 |
Why?
|
| Parkinson Disease | 1 | 2021 | 272 | 0.160 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 166 | 0.160 |
Why?
|
| Wound Healing | 1 | 2019 | 260 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 195 | 0.150 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 235 | 0.150 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2007 | 9 | 0.150 |
Why?
|
| Acinar Cells | 1 | 2016 | 8 | 0.150 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 48 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 2 | 2009 | 290 | 0.140 |
Why?
|
| Pancreatic Ducts | 1 | 2016 | 76 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 328 | 0.140 |
Why?
|
| Skin | 1 | 2019 | 451 | 0.140 |
Why?
|
| Chemokines | 1 | 2016 | 119 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2021 | 447 | 0.140 |
Why?
|
| COS Cells | 2 | 2013 | 155 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 2009 | 597 | 0.130 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 442 | 0.130 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2013 | 3 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 2 | 2019 | 164 | 0.120 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2013 | 44 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2018 | 23 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 626 | 0.110 |
Why?
|
| Gene Expression | 3 | 2016 | 770 | 0.110 |
Why?
|
| Mice, Knockout | 5 | 2021 | 1692 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2013 | 756 | 0.100 |
Why?
|
| DNA Methylation | 2 | 2010 | 192 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 1533 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2010 | 320 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2010 | 11 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 33 | 0.090 |
Why?
|
| Humans | 18 | 2021 | 68525 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2009 | 22 | 0.090 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2009 | 13 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 94 | 0.090 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2009 | 65 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2009 | 137 | 0.090 |
Why?
|
| Cherubism | 1 | 2008 | 2 | 0.090 |
Why?
|
| Osteoprotegerin | 1 | 2008 | 11 | 0.080 |
Why?
|
| Endosomes | 1 | 2009 | 45 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 107 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2010 | 447 | 0.080 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2008 | 30 | 0.080 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2008 | 5 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2009 | 100 | 0.080 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2008 | 12 | 0.080 |
Why?
|
| Gene Deletion | 3 | 2016 | 235 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2009 | 396 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 114 | 0.080 |
Why?
|
| Inflammation | 2 | 2019 | 1030 | 0.080 |
Why?
|
| Integrin beta3 | 1 | 2008 | 35 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 199 | 0.080 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2007 | 26 | 0.080 |
Why?
|
| Cholesterol | 1 | 2009 | 331 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2007 | 27 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2009 | 523 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 396 | 0.070 |
Why?
|
| Chloride Channels | 1 | 2006 | 22 | 0.070 |
Why?
|
| 14-3-3 Proteins | 1 | 2006 | 12 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2009 | 384 | 0.070 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2021 | 22 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2009 | 1663 | 0.060 |
Why?
|
| Collagen | 2 | 2019 | 636 | 0.060 |
Why?
|
| Cell Line | 3 | 2019 | 1752 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1860 | 0.060 |
Why?
|
| Aging | 1 | 2009 | 911 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 2018 | 182 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 2550 | 0.050 |
Why?
|
| MPTP Poisoning | 1 | 2002 | 10 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2010 | 1032 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 1849 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2006 | 617 | 0.050 |
Why?
|
| Apoptosis | 1 | 2009 | 1640 | 0.050 |
Why?
|
| Antioxidant Response Elements | 1 | 2021 | 10 | 0.050 |
Why?
|
| Base Sequence | 3 | 2008 | 1015 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 493 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 137 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 1446 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 211 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2019 | 1173 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2021 | 107 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 265 | 0.050 |
Why?
|
| Phenotype | 2 | 2016 | 946 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2002 | 382 | 0.050 |
Why?
|
| Protein Binding | 3 | 2008 | 1027 | 0.050 |
Why?
|
| Antioxidants | 1 | 2002 | 304 | 0.040 |
Why?
|
| Granulation Tissue | 1 | 2019 | 6 | 0.040 |
Why?
|
| Neutrophil Infiltration | 1 | 2019 | 35 | 0.040 |
Why?
|
| Streptozocin | 1 | 2019 | 34 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 498 | 0.040 |
Why?
|
| Dermis | 1 | 2019 | 29 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2002 | 317 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2019 | 131 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 138 | 0.040 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2018 | 3 | 0.040 |
Why?
|
| CCCTC-Binding Factor | 1 | 2018 | 5 | 0.040 |
Why?
|
| Mice, Inbred mdx | 1 | 2018 | 10 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 238 | 0.040 |
Why?
|
| Zinc Fingers | 2 | 2009 | 17 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2018 | 32 | 0.040 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2018 | 69 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2009 | 2790 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1548 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2019 | 223 | 0.040 |
Why?
|
| Metaplasia | 1 | 2016 | 27 | 0.040 |
Why?
|
| Transfection | 2 | 2008 | 782 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 78 | 0.040 |
Why?
|
| Neurons | 1 | 2021 | 881 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 929 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 700 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1174 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 2013 | 41 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 5300 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2013 | 124 | 0.030 |
Why?
|
| Quality of Life | 1 | 2021 | 1515 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4843 | 0.030 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2010 | 13 | 0.020 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2010 | 13 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 64 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2009 | 59 | 0.020 |
Why?
|
| Methylation | 1 | 2009 | 56 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2009 | 31 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 81 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 2009 | 18 | 0.020 |
Why?
|
| Chimera | 1 | 2009 | 33 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 94 | 0.020 |
Why?
|
| Female | 3 | 2021 | 38015 | 0.020 |
Why?
|
| Fetal Death | 1 | 2009 | 49 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2009 | 3 | 0.020 |
Why?
|
| Calgranulin A | 1 | 2009 | 5 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2009 | 15 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2009 | 17 | 0.020 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2009 | 22 | 0.020 |
Why?
|
| Homozygote | 1 | 2009 | 119 | 0.020 |
Why?
|
| Edema | 1 | 2009 | 66 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2009 | 114 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2009 | 133 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 2009 | 64 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 134 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2009 | 118 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 306 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 196 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2009 | 42 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2009 | 156 | 0.020 |
Why?
|
| Histones | 1 | 2009 | 111 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2009 | 102 | 0.020 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2009 | 44 | 0.020 |
Why?
|
| Base Pairing | 1 | 2008 | 15 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2008 | 51 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2009 | 92 | 0.020 |
Why?
|
| RNA Interference | 1 | 2009 | 266 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2008 | 95 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2009 | 62 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 60 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 67 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 852 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2009 | 311 | 0.020 |
Why?
|
| Carcinoma | 1 | 2010 | 215 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 532 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 89 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 272 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 132 | 0.020 |
Why?
|
| Colitis | 1 | 2009 | 156 | 0.020 |
Why?
|
| Male | 2 | 2021 | 37281 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 216 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 226 | 0.020 |
Why?
|
| Phylogeny | 1 | 2008 | 196 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 316 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 65 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2009 | 328 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2006 | 14 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 631 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 62 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 901 | 0.020 |
Why?
|
| Alleles | 1 | 2006 | 386 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 14842 | 0.020 |
Why?
|
| Protein Transport | 1 | 2006 | 280 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 434 | 0.020 |
Why?
|
| Computational Biology | 1 | 2006 | 190 | 0.020 |
Why?
|
| Proteins | 1 | 2009 | 473 | 0.020 |
Why?
|
| Kinetics | 1 | 2006 | 1047 | 0.020 |
Why?
|
| Citric Acid | 1 | 2002 | 16 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 2002 | 18 | 0.010 |
Why?
|
| Free Radicals | 1 | 2002 | 65 | 0.010 |
Why?
|
| Dopamine Agents | 1 | 2002 | 56 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2002 | 54 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 981 | 0.010 |
Why?
|
| Substantia Nigra | 1 | 2002 | 102 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 201 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 163 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 7028 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 1172 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 4655 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2002 | 718 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 7264 | 0.010 |
Why?
|